Stephen Slade is listed as a director on 4 SEC Form D filings by 2 issuers between Apr 2013 and Jun 2023: REVISION OPTICS INC (Lake Forest, CA — other technology — 2013–2016; $39.7M reported sold to 13 investors) and Stroma Medical Corp (Irvine, CA — other technology — 2023; $39.4M reported sold to 144 investors).
What this means 2 separate companies raised money with this person listed as director, over about 10 years. Across those companies the filings report $79.1M sold in total.
Listed alongside Alain Schreiber (3 shared filings), Brian H. Dovey (3 shared filings), John T. Kilcoyne (3 shared filings), Randy Alexander (3 shared filings), Wende Hutton (3 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stephen. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 4 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Stephen Slade and found 3 differences, 1 worth asking the sponsor about: Form D filed 807 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.